SCHEMBL3298741

SCHEMBL3298741

COc1cc(C(C)(C)C)ccc1[SiH](O[SiH](c1ccc(C(C)(C)C)cc1OC)c1ccc(C(C)(C)C)cc1OC)c1ccc(C(C)(C)C)cc1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
HTT P42858 1/20 0.37
FGFR2 P21802 1/20 0.36
GAK O14976 1/20 0.36
RIPK2 O43353 1/20 0.36
COQ8A Q8NI60 1/20 0.36
NLK Q9UBE8 1/20 0.36
NR1H4 Q96RI1 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
LMNA P02545 1/20 0.34
TYR P14679 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3295208 0.87 ALDH1A1 (0.41) CA1CA2CA9ALDH1A1SMN1; SMN2
SCHEMBL3297570 0.81 ALDH1A1 (0.38) CA1CA2CA9ALDH1A1KMT2A
SCHEMBL3296126 0.81 ALDH1A1 (0.40) CA1CA2CA9ALDH1A1SMN1; SMN2
SCHEMBL3301492 0.77 KDM4E (0.40) ALDH1A1SMN1; SMN2MAPTNPSR1
SCHEMBL29436012 0.76 CA2 (0.50) CA1CA2CA9ALDH1A1SMN1; SMN2
SCHEMBL179467 0.76 CA2 (0.50) CA1CA2CA9ALDH1A1SMN1; SMN2
SCHEMBL29021651 0.75 CA1 (0.42) CA1CA2CA9ALDH1A1SMN1; SMN2
SCHEMBL3295456 0.75 ACHE (0.56) ALDH1A1SMN1; SMN2KMT2AMEN1HPGD
SCHEMBL3302017 0.75 CA12 (0.56) CA1CA2CA9ALDH1A1KMT2A
SCHEMBL3296168 0.73 ALDH1A1 (0.38) CA1CA2CA9ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 CA1 2428/4885CA2 3413/4885CA9 1115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.